Mirador Biomedical, based in Seattle, makes the Compass pressure measurement device to improve safety in vascular access procedures.
Founded in 2009 and headquartered in Seattle, US, Mirador Biomedical develops medical devices, including the Compass pressure measurement device, which helps prevent inadvertent arterial cannulation during procedures such as thoracentesis and lumbar puncture. The company became part of Centurion Medical Products in October 2014. Its most recent deal, on October 1, 2014, raised USD 1.50 mn in a Series B round from Summit Capital and WRF Capital, for a total of USD 1.50 mn raised.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in